ThermoGenesis Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Xiaochun Xu
- Full Time Employees
- 25
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 2711 Citrus Road Rancho Cordova CA United States of America 95742
- IPO Date
- Jun 5, 1987
- CIK
- 0000811212
- Website
- thermogenesis.com
- Similar Companies
- Business
- ThermoGenesis Holdings, Inc. (THMO) develops, manufactures, and sells medical devices and services focused on cell and cell therapy processing for the regenerative medicine industry. The company offers the BioArchive System for automated cryopreservation of hematopoietic stem cells; the semi-automated ThermoGenesis X-Series for cell washing, culture, and formulation; the sterile processing disposable AXP II for collecting and concentrating stem cells; and related services including automated processing, cryopreservation, and cell therapy logistics. These products support cord blood banks, transplant centers, and cell therapy developers worldwide. ThermoGenesis Holdings, Inc., founded in 1986, is headquartered in Rancho Cordova, California, and operates primarily in the United States with distribution in Europe and Asia. In recent developments, the company has expanded its strategic focus on point-of-care cell therapy solutions through enhanced partnerships with leading regenerative medicine firms and the launch of next-generation disposable kits for its X-Series platform in 2024.
CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
Why Is ThermoGenesis (THMO) Stock Up 54% Today?
Why ThermoGenesis Stock Is Soaring Wednesday
THMO Stock Alert: Why ThermoGenesis Is Up 95% Today
ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Reports Q3 Loss, Misses Revenue Estimates
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update